215 related articles for article (PubMed ID: 23288172)
1. Functional role of soluble receptor for advanced glycation end products in stroke.
Tang SC; Wang YC; Li YI; Lin HC; Manzanero S; Hsieh YH; Phipps S; Hu CJ; Chiou HY; Huang YS; Yang WS; Mattson MP; Arumugam TV; Jeng JS
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):585-94. PubMed ID: 23288172
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.
Lok KZ; Basta M; Manzanero S; Arumugam TV
J Neuroinflammation; 2015 Apr; 12():73. PubMed ID: 25886362
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
[TBL] [Abstract][Full Text] [Related]
4. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
Wittwer C; Boeck S; Heinemann V; Haas M; Stieber P; Nagel D; Holdenrieder S
Int J Cancer; 2013 Dec; 133(11):2619-30. PubMed ID: 23729200
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
6. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
Wang J; Wang H; Shi J; Ding Y
Int J Clin Exp Pathol; 2015; 8(10):12028-40. PubMed ID: 26722388
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.
Kocsis AK; Szabolcs A; Hofner P; Takács T; Farkas G; Boda K; Mándi Y
Pancreatology; 2009; 9(4):383-91. PubMed ID: 19451748
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble RAGE increase after a cerebrovascular event.
Menini T; Ikeda H; Kimura S; Gugliucci A
Clin Chem Lab Med; 2014 Jan; 52(1):109-16. PubMed ID: 23492566
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis.
Lindström O; Tukiainen E; Kylänpää L; Mentula P; Rouhiainen A; Puolakkainen P; Rauvala H; Repo H
Pancreas; 2009 Nov; 38(8):e215-20. PubMed ID: 19786934
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
11. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
Tang KT; Hsieh TY; Chao YH; Lin MX; Chen YH; Chen DY; Lin CC
PLoS One; 2017; 12(5):e0178404. PubMed ID: 28558055
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
[TBL] [Abstract][Full Text] [Related]
14. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
Yokota C; Minematsu K; Tomii Y; Naganuma M; Ito A; Nagasawa H; Yamaguchi T
J Neurol Sci; 2009 Dec; 287(1-2):41-4. PubMed ID: 19801152
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the receptor for advanced glycation end products in liver transplantation.
Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
[TBL] [Abstract][Full Text] [Related]
16. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity.
Yoshizaki A; Komura K; Iwata Y; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Clin Immunol; 2009 Mar; 29(2):180-9. PubMed ID: 18825489
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
19. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
Greco R; Tassorelli C; Mangione AS; Levandis G; Certo M; Nappi G; Bagetta G; Blandini F; Amantea D
Eur J Pharmacol; 2014 Dec; 744():91-7. PubMed ID: 25446913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
